Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kowal, S. Zukowski, L. M. DuBuske, A. Bodzenta-Lukaszyk (Bialystok, Poland; Gardner, United States Of America). Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough. Eur Respir J 2006; 28: Suppl. 50, 2563

Member's Comments

No comment yet.

Related content which might interest you: Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 Oral montelukast in patients with acute severe asthma Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 Montelukast as add-on therapy in severe noninfectious COPD exacerbations Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003 Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Efficacy of montelukast in Indian patients having chronic persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 372s Year: 2003 Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma Source: Eur Respir J, 57 (2) 2003064; 10.1183/13993003.03064-2020 Year: 2021 Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009 Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma Year: 2006 Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Source: Eur Respir J 2005; 25: 41-46 Year: 2005 Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Nebulized therapy in bronchial asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 The role of nebulised budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2007; 30: 399-400 Year: 2007 Rescue-free days in patients with mild persistent asthma receiving montelukast sodium or an inhaled corticosteroid Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002 Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006 Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma Source: Eur Respir J 2015; 45: 1273-1282 Year: 2015 Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006 Use of budesonide suspension during the exacerbation of severe steroid-dependent bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Inhaled budesonide for the treatment of chronic wheezing in early childhood Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 The role of nebulised budesonide in the treatment of exacerbations of COPD Source: Eur Respir J 2007; 29: 660-667 Year: 2007